Author: mattstrongalldaylong

A new blood-based test could help doctors better predict treatment success and disease progression in patients with Ewing Sarcoma. Researchers

A major step forward has been made in immunotherapy, specifically focusing on a cancer treatment strategy called the “CD47-SIRPα axis.”

A new position statement from the American Society of Clinical Oncology (ASCO) is aimed at making it easier for children

This article explores another promising treatment strategy for Ewing Sarcoma. Doctors often treat this cancer with drugs that damage the

This research article identifies a major Achilles’ heel in Ewing Sarcoma, an aggressive bone and soft tissue cancer that primarily

Researchers recently discovered that a specific viral receptor gene called CXADR is highly active in patients with the worst Ewing

A recent study presented at the 2026 ASCO Annual Meeting reveals that an oral drug called abemaciclib (brand name Verzenio)

Adolescent and young adult (AYA) patients with sarcoma often fall into a medical “gray area” because they are too old

Researchers have discovered that a specific protein called UBA1 is found in much higher amounts in Ewing Sarcoma cells compared